CAMP4 Therapeutics Corp (CAMP) PT Raised to $9 at Leerink Partners
Leerink Partners analyst Mani Foroohar raised the price target on CAMP4 Therapeutics Corp (NASDAQ: CAMP) to $9.00 (from $8.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
